DVN vs GTBP · P/E 7.4, rev $7.42B vs $17.4M cap
Devon Energy Corporation (DVN) versus GT Biopharma Inc (GTBP) — a side-by-side from cached financials, not a winner call.
Devon Energy Corporation (DVN) is a oil & gas e&p company listed on US.
GT Biopharma Inc (GTBP) is a biotechnology company listed on NASDAQ.
Latest reported DVN revenue for 2026-06-30 was $7.42B. Net income was $1.91B. Revenue was up 94.8% from 2026-03-31 to 2026-06-30. DVN currently screens at market cap $22.42B and trailing P/E 7.4.
GTBP does not have a complete income-statement cache yet.
DVN currently screens at market cap $22.42B and trailing P/E 7.4. GTBP currently screens at market cap $17.4M.
Not investment advice. Open the DVN and GTBP stock pages for the full models.
Not investment advice.